Sign Up
OverviewAPI
Global banks and financial institutions are linked to Chinese pharmaceutical companies using leopard and pangolin parts in traditional Chinese medicine (TCM), prompting calls for divestment. Three listed Chinese firms, including Beijing Tong Ren Tang, Tianjin Pharmaceutical, and Jilin Aodong Pharmaceutical Group, have been accused of using endangered animal parts as ingredients in their products, leading to an investigation by the SEC.

Ask a question